{
    "title": "Pfizer slashes revenue forecast on lower COVID sales, will cut costs",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12629437/Pfizer-slashes-2023-revenue-forecast-lower-COVID-sales-cut-expenses-jobs.html",
    "date": "2023-10-13",
    "keywords": [
        "revenue",
        "pfizer",
        "year",
        "vaccine",
        "paxlovid",
        "treatment",
        "covid",
        "forecast",
        "vaccination",
        "company",
        "government",
        "erman",
        "covid19",
        "demand",
        "program",
        "end",
        "drug",
        "reporting",
        "friday",
        "worth",
        "record",
        "comirnaty",
        "partner",
        "biontech",
        "se",
        "populationwide",
        "immunity",
        "fall",
        "breakthroughs",
        "role",
        "health",
        "crisis",
        "control",
        "ceo",
        "albert",
        "boura",
        "statement",
        "clarity",
        "level",
        "supply",
        "drugmaker",
        "reduction",
        "charge",
        "quarter",
        "inventory",
        "costcutting",
        "trading",
        "reversal",
        "return",
        "deal",
        "credit",
        "freeofcharge",
        "medicare",
        "medicaid",
        "insurance",
        "jan",
        "track",
        "growth",
        "roy",
        "bengaluru",
        "editing",
        "bill",
        "berkrot",
        "rod",
        "nickel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}